GLSI
Price
$9.20
Change
-$0.27 (-2.85%)
Updated
Jun 13 closing price
Capitalization
122.99M
57 days until earnings call
NGENF
Price
$2.73
Change
-$0.20 (-6.83%)
Updated
Jun 13 closing price
Capitalization
196.84M
Interact to see
Advertisement

GLSI vs NGENF

Header iconGLSI vs NGENF Comparison
Open Charts GLSI vs NGENFBanner chart's image
Greenwich LifeSciences
Price$9.20
Change-$0.27 (-2.85%)
Volume$23.03K
Capitalization122.99M
NervGen Pharma
Price$2.73
Change-$0.20 (-6.83%)
Volume$192.44K
Capitalization196.84M
GLSI vs NGENF Comparison Chart
Loading...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NGENF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLSI vs. NGENF commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLSI is a StrongBuy and NGENF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (GLSI: $9.20 vs. NGENF: $2.73)
Brand notoriety: GLSI and NGENF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLSI: 42% vs. NGENF: 68%
Market capitalization -- GLSI: $122.99M vs. NGENF: $196.84M
GLSI [@Biotechnology] is valued at $122.99M. NGENF’s [@Biotechnology] market capitalization is $196.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLSI’s FA Score shows that 0 FA rating(s) are green whileNGENF’s FA Score has 0 green FA rating(s).

  • GLSI’s FA Score: 0 green, 5 red.
  • NGENF’s FA Score: 0 green, 5 red.
According to our system of comparison, NGENF is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLSI’s TA Score shows that 2 TA indicator(s) are bullish while NGENF’s TA Score has 4 bullish TA indicator(s).

  • GLSI’s TA Score: 2 bullish, 6 bearish.
  • NGENF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NGENF is a better buy in the short-term than GLSI.

Price Growth

GLSI (@Biotechnology) experienced а -4.76% price change this week, while NGENF (@Biotechnology) price change was +13.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

GLSI is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NGENF($197M) has a higher market cap than GLSI($123M). NGENF YTD gains are higher at: 25.229 vs. GLSI (-18.077). GLSI has higher annual earnings (EBITDA): -16.75M vs. NGENF (-25.94M). NGENF has more cash in the bank: 14.6M vs. GLSI (2.75M). GLSI (0) and NGENF (0) have equivalent revenues.
GLSINGENFGLSI / NGENF
Capitalization123M197M62%
EBITDA-16.75M-25.94M65%
Gain YTD-18.07725.229-72%
P/E RatioN/AN/A-
Revenue00-
Total Cash2.75M14.6M19%
Total DebtN/A81.8K-
FUNDAMENTALS RATINGS
NGENF: Fundamental Ratings
NGENF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
58
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLSINGENF
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 20 days ago
78%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
71%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NGENF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAMPX14.170.05
+0.35%
GS Energy Infrastructure Fd P
HLQVX19.73-0.21
-1.05%
JPMorgan Large Cap Value I
WBIRX30.07-0.37
-1.22%
William Blair International Growth R6
ASCRX14.36-0.28
-1.91%
American Century Small Company R
RSMVX10.24-0.20
-1.92%
William Blair Small-Mid Cap Value R6

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ABOS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-2.85%
ABOS - GLSI
43%
Loosely correlated
-6.14%
XBIT - GLSI
41%
Loosely correlated
-4.35%
DNLI - GLSI
41%
Loosely correlated
-2.51%
GBIO - GLSI
40%
Loosely correlated
-3.63%
CLDX - GLSI
39%
Loosely correlated
+4.47%
More

NGENF and

Correlation & Price change

A.I.dvisor tells us that NGENF and INO have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NGENF and INO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGENF
1D Price
Change %
NGENF100%
-6.93%
INO - NGENF
23%
Poorly correlated
-3.85%
CYCC - NGENF
23%
Poorly correlated
+14.79%
GLSI - NGENF
22%
Poorly correlated
-2.85%
ZLDPF - NGENF
22%
Poorly correlated
-5.46%
SLDB - NGENF
22%
Poorly correlated
-1.53%
More